1JS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Shield Therapeutics PLC

Watchlist Manager

Watchlist

Price: 0.043 EUR 8.86% Market Closed

Market Cap: €33.6m

S	Shield Therapeutics PLC F:1JS	UK
	Elma Electronic AG F:312	CH
	Focus Minerals Ltd OTC:FCSUF	AU
E	Enduro Metals Corp OTC:ENDMF	CA

Profitability Summary

Shield Therapeutics PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

46%

Sustainable 3Y Average Gross Margin

41%

Gross Margin is Increasing

45% > 46%

Negative Operating Margin

-20%

Negative 3Y Average Operating Margin

-106%

Operating Margin is Increasing

-390% > -20%

Negative Net Margin

-36%

Negative 3Y Average Net Margin

-120%

Net Margin is Increasing

-655% > -36%

Negative Free Cash Flow Margin

-7%

Negative 3Y Average Free Cash Flow Margin

-89%

Free Cash Flow Margin is Increasing

-360% > -7%

Exceptional ROE

215%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-115%

ROIC is Increasing

-101% > -64%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.